Introducing the hs-cTnI Rapid Quantitative Test, in conjunction with the Aehealth FIA Meter, by AEHEALTH LIMITED. This innovative product is designed for the precise and rapid determination of Cardiac troponin I (cTnI) in human whole blood, serum, or plasma. The high-sensitivity of this test makes it an invaluable tool for the auxiliary diagnosis of myocardial infarction, aiding healthcare professionals in making critical decisions for patient care. The test provides accurate quantitative results, allowing for quick and efficient assessment of cTnI levels. With the Aehealth FIA Meter, the hs-cTnI Rapid Quantitative Test offers a user-friendly and reliable solution for healthcare facilities. Trust in AEHEALTH LIMITED for cutting-edge diagnostic products to support improved patient outcomes.

• Acute heart failure
• Chronic heart failure
• Acute coronary syndrome

• Diagnose and treat various fibrinolytic system diseases
• Thrombosis
• Thrombolytic therapy monitoring

• Acute myocardial infarction
• Evaluation of thrombolytic therapy
• Determine the size of acute myocardial infarction

• Acute myocardial infarction
• Acute pulmonary embolism
• Some other reasons:Severe infection,Severe heart failure, Connective tissue disease, Acute myocarditis, etc.

• Ck-mb detection is very important for the diagnosis of myocardial ischemia, in acute myocardial infarction, myocarditis, CK-MB in chest pain 3-8 hours will increase, and can be detected in a longer period of time

• Screening indicators for AMI
• Determine myocardial reinfarction or infarct expansion
• Judging the efficacy of thrombolysis

• Diagnose myocardial infarction
• Evaluate the effect of thrombolytic therapy
• Evaluation of the scope of re-embolization and embolization
• Improve early sensitivity and late specificity in the diagnosis of heart disease

• Diagnosis of heart failure in clinical work
• Risk classification of patients with heart failure
• Predict sudden cardiac death
• Monitoring the therapeutic effect of patients with heart failure and evaluating the prognosis
• Differential diagnosis of patients with acute dyspnea
• Assess the prognosis of patients with acute coronary syndrome
• Preoperative, intraoperative, and postoperative monitoring